Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-20 | Black Diamond Therapeutics, Inc. | Behbahani Ali
(Director) |
A | Common Stock | A | 3007 | $4.78 - $4.78 | $14,373 |
| 2024-09-20 | Black Diamond Therapeutics, Inc. | Campbell Shannon
(Director) |
A | Common Stock | A | 2354 | $4.78 - $4.78 | $11,252 |
| 2024-09-20 | Black Diamond Therapeutics, Inc. | Raman Prakash
(Director) |
A | Common Stock | A | 2694 | $4.78 - $4.78 | $12,877 |
| 2024-08-28 | Black Diamond Therapeutics, Inc. | Versant Vantage I...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 221600 | $6.32 - $6.32 | $1,400,556 |
| 2024-06-21 | Black Diamond Therapeutics, Inc. | Behbahani Ali
(Director) |
A | Common Stock | A | 2887 | $4.98 - $4.98 | $14,377 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |